Abstract
Mucocutaneous vascular ectasia, otherwise referred to as telangiectasia, can be an important harbinger of serious systemic disease. Among a variety of acquired conditions, including hepatic cirrhosis that are responsible for their development, are a heterogeneous group of inherited conditions that entail the development of multiple cutaneous and mucous membrane vascular lesions associated with other life-threatening complications. This chapter deals with the clinical and pathologic features of three such conditions, namely Osler-Weber-Rendu syndrome, ataxiatelangiectasia, and Fabry’s disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
OWR
Osler W. On multiple hereditary telangiectasis with recurrent ring hemorrhages. Q J Med 1907;1:53.
Perry W. The clinical spectrum of hereditary hemorrhagic telangiectasias (Osler-Weber-Rendu). Am J Med 1987;5:989.
Chandler D. Pulmonary and cerebral arteriovenous fistula with Osler’s disease. Arch Intern Med 1965;116:277.
Swanson D, Dahl M. Embolic abscesses in hereditary hemorrhagic telangiectasia. J Am Acad Dermatol 1991;24:580.
Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia: A double blind controlled clinical trial. Acta Med Scand 1981;209:393.
AT
Smith L, Conerly S. Ataxia-telangiectasia or Louis-Bar syndrome. J Am Acad Dermatol 1985;12:686.
Li A, Swift M. Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am J Med Genet 2000;92:170.
Khanna K. Cancer risk and the ATM gene: A continuing debate. J Natl Cancer Inst 2000;92:795.
Swift M, Morrell D, Massey R, et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991;325:1831.
Peterson R, Funkhouser J. Speculations on ataxiatelangiectasia: Defective regulation of the immunoglobulin gene superfamily. Immunol Today 1989;10:313.
Drolet B, Drolet B, Zvulunov A, et al. Cutaneous granulomas as a presenting sign in ataxia-telangiectasia. Dermatology 1997;194:273.
FD
Anderson W. A case of angiokeratoma. Br J Dermatol 1898;10:113.
Fabry J. Ein Beitrag Zur Kenntis der Purpura haemorrhagica nodularis. Arch Dermatol Syphilol 1898;43:187.
Eng C, Guffon N, Wilcox W, et al. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry’s disease. N Engl J Med 2001;345:9.
Wallace H. Anderson-Fabry disease. Br J Dermatol 1973;88:1.
Holmes R, Fenson A, McKee P, et al. Angiokeratoma corporis diffusum in a patient with normal enzyme activities. J Am Acad Dermatol 1984;10:384.
Epinette W, Norins A, Drew A, et al. Angiokeratoma corporis diffusum with a L-fucosidase deficiency. Arch Dermatol 1973;107:754.
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
(2007). Lethal Hereditary Vascular Disorders: Osler-Weber-Rendu, Ataxia-Telangiectasia, and Fabry’s Disease. In: Deadly Dermatologic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68858-9_30
Download citation
DOI: https://doi.org/10.1007/978-0-387-68858-9_30
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-25442-5
Online ISBN: 978-0-387-68858-9
eBook Packages: MedicineMedicine (R0)